BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2018
View Archived Issues
Armis Biopharma's Ximycin designated as QIDP by FDA
Read More
Sumitomo Dainippon Pharma highlights progress of third quarter of fiscal 2017
Read More
First patient treated in phase III study of BeiGene's tislelizumab
Read More
Dermira begins phase IIb study of lebrikizumab in moderate to severe atopic dermatitis
Read More
Preclinical data presented for adipoRon in cholangiocarcinoma
Read More
Sage Therapeutics' SAGE-217 improves sleep efficiency and sleep time in model of insomnia
Read More
FDA gives Protalix Biotherapeutics' PRX-102 fast track designation
Read More
Oncolix sponsoring evaluation of Prolanta for other gynecological cancers
Read More
Cara Therapeutics begins pivotal phase III study of Korsuva in CKD-associated pruritus
Read More
Acasti initiates TRILOGY trials of CaPre in patients with severe hypertriglyceridemia
Read More
Vertex selects VX-659 and VX-445 to advance into phase III cystic fibrosis triple combination trials
Read More
Phase III U.S. study of transdermal patch for schizophrenia meets primary endpoint
Read More
IDO1 as an indicator of poor outcome in anal squamous cell carcinoma
Read More
First patient treated in clinical study of ONC-201 in children with H3 K27M mutant glioma
Read More
AbGenomics' neihulizumab granted orphan drug status in U.S. for aGvHD
Read More
Vaxart's oral influenza tablet vaccine demonstrates reduction in rate of influenza infection
Read More
Medshine Discovery patents new PPAR agonists
Read More
Gemphire initiates phase IIa trial of gemcabene for pediatric NAFLD
Read More
Seattle Genetics enters definitive merger agreement to acquire Cascadian Therapeutics
Read More
Cadila Healthcare divulges novel RORgamma inverse agonists
Read More
Bristol-Myers Squibb discloses PD-1/PD-L1 interaction inhibitors
Read More
Japanese researchers present compounds for Parkinson's disease
Read More
Galecto Biotech discovers galectin inhibitors
Read More
AstraZeneca initiates phase IIa study of AZD-9567 in rheumatoid arthritis
Read More
Lanreotide effective for prolonged control of carcinoid syndrome symptoms
Read More